2ND MALIGNANCIES FROM ADJUVANT CHEMOTHERAPY - TOO SOON TO TELL

被引：11

作者：

HENDERSON, IC ^{[1
]}

GELMAN, R ^{[1
]}

机构：

[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 08期

关键词：

D O I：

10.1200/JCO.1987.5.8.1135

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1135 / 1137

页数：3

相关论文

共 13 条

[1] STUDIES OF MORTALITY OF A-BOMB SURVIVORS .6. MORTALITY AND RADIATION-DOSE, 1950-1974
BEEBE, GW
KATO, H
LAND, CE
[J]. RADIATION RESEARCH, 1978, 75 (01) : 138 - 201
[2] BRINKLEY D, 1987, COMMUNICATION MAY
[3] CUZICK J, 1987, CANCER TREAT REP, V71, P15
[4] LEUKEMIA IN BREAST-CANCER PATIENTS FOLLOWING ADJUVANT CHEMOTHERAPY OR POSTOPERATIVE RADIATION - THE NSABP EXPERIENCE
FISHER, B
ROCKETTE, H
FISHER, ER
WICKERHAM, DL
REDMOND, C
BROWN, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) : 1640 - 1658
[5] MELPHALAN MAY BE A MORE POTENT LEUKEMOGEN THAN CYCLOPHOSPHAMIDE
GREENE, MH
HARRIS, EL
GERSHENSON, DM
MALKASIAN, GD
MELTON, LJ
DEMBO, AJ
BENNETT, JM
MOLONEY, WC
BOICE, JD
[J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) : 360 - 367
[6] CARCINOGENIC ACTIVITY IN RATS OF COMBINED TREATMENT WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL
HABS, M
SCHMAHL, D
LIN, PZ
[J]. INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (01) : 91 - 96
[7] HENDERSON IC, 1987, CURR PROB CANCER, V11, P127
[8] OCCURRENCE OF 2ND PRIMARY MALIGNANCIES IN MAN - A 2ND LOOK
HENNE, T
SCHMAHL, D
[J]. CANCER TREATMENT REVIEWS, 1985, 12 (02) : 77 - 94
[9] LERNER HJ, 1978, CANCER TREAT REP, V62, P1135
[10] 2ND MALIGNANCIES AFTER CMF FOR RESECTABLE BREAST-CANCER
VALAGUSSA, P
TANCINI, G
BONADONNA, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1138 - 1142